Geron Appoints Former Vanda GC Timothy Williams as Chief Legal Officer
Geron named Timothy Williams as EVP, Chief Legal Officer and Corporate Secretary on April 13, 2026. Williams, formerly General Counsel at Vanda Pharmaceuticals and head of M&A and securities groups at Stryker, brings expertise that will support commercialization of RYTELO and a pivotal Phase 3 imetelstat trial in myelofibrosis.
1. Appointment Details
On April 13, 2026, Geron named Timothy Williams as Executive Vice President, Chief Legal Officer and Corporate Secretary. He will oversee the company's global legal, compliance and corporate governance functions.
2. Career Background
Williams joins from Vanda Pharmaceuticals where he served as Senior Vice President, General Counsel and Secretary from 2018 to March 2026. He previously led global M&A, corporate governance and securities groups at Stryker and held senior legal roles at AgNovos Bioscience, Mayer Brown and Bryan Cave.
3. Strategic Impact
Williams’s expertise in biopharmaceutical legal operations and M&A is expected to support Geron’s commercial launch of RYTELO and the pivotal Phase 3 imetelstat trial in relapsed/refractory myelofibrosis. His addition complements recent board appointments to strengthen governance and strategic counsel.